-
Aug 12, 2026
FDA's advisory committee process is one of the agency's greatest institutional strengths. No other major drug regulator conducts scientific advisory meetings as publicly -- or as...
-
Aug 5, 2026
The FDA advisory committee's recent vote against Capricor Therapeutics' cell therapy for Duchenne muscular dystrophy looked like a decision about one product. It may ultimately be...
-
Feb 5, 2026
A milestone in the treatment of Duchenne muscular dystrophy (DMD) passed recently with remarkably little public notice. That silence is a sign of progress. For years, advances in DMD...
-
Feb 4, 2026
A milestone in the treatment of Duchenne muscular dystrophy (DMD) passed recently with remarkably little public notice. That silence is a sign of progress. For years, advances in DMD...
-
Jan 27, 2026
Every president promises to fix health care -- but the system rarely seems to change for the better. Even when so-called reforms pass, prices remain unpredictable. Costs continue to...
Aug 12, 2026FDA's advisory committee process is one of the agency's greatest institutional strengths. No other major drug regulator conducts scientific advisory meetings as publicly -- or as...
Aug 5, 2026The FDA advisory committee's recent vote against Capricor Therapeutics' cell therapy for Duchenne muscular dystrophy looked like a decision about one product. It may ultimately be...
Feb 5, 2026A milestone in the treatment of Duchenne muscular dystrophy (DMD) passed recently with remarkably little public notice. That silence is a sign of progress. For years, advances in DMD...
Jan 27, 2026Every president promises to fix health care -- but the system rarely seems to change for the better. Even when so-called reforms pass, prices remain unpredictable. Costs continue to...